Table 1.
Group A | Group B | P value | |
---|---|---|---|
Number of patients (n) | 99 | 97 | |
Age (years) | 64.8 ± 13.9 | 63.4 ± 13.3 | 0.45 |
Sex, male | 48 (48.5%) | 51 (52.6%) | 0.57 |
BMI (kg/m2) | 23.2 ± 4.0 | 22.5 ± 2.8 | 0.17 |
Alcohol drinking | 48 (48.5%) | 37 (38.1%) | 0.15 |
Smoking | 38 (38.4%) | 34 (35.1%) | 0.66 |
History of colonoscopy | 46 (46.4%) | 46 (47.4%) | 1.00 |
Using laxative | 5 (5.0%) | 5 (5.2%) | 1.00 |
Using sleeping pills | 4 (4.0%) | 4 (4.1%) | 1.00 |
Using antithrombotic agents | 15 (15.2%) | 15 (15.5%) | 1.00 |
Comorbidity | |||
Cardiovascular diseases | 14 (14.1%) | 17 (17.5%) | 0.56 |
Cerebrovascular diseases | 5 (5.0%) | 9 (9.3%) | 0.28 |
Chronic kidney diseases | 3 (3.0%) | 1 (1.0%) | 0.62 |
Chronic liver damage | 5 (5.0%) | 5 (5.2%) | 1.00 |
Diabetes mellitus | 14 (14.1%) | 7 (7.2%) | 0.17 |
Hypertension | 35 (35.4%) | 40 (41.2%) | 0.46 |
Malignant diseases | 22 (22.2%) | 15 (15.5%) | 0.27 |
Charlson comorbidity score | 1.4 ± 1.7 | 1.2 ± 1.2 | 0.38 |
BMI, body mass index. Results are presented as mean ± standard deviation or number of patients.